Enterprise Value
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary:
Nymox Pharmaceutical enterprise value is not available.NYMX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| 6 m6 months | - | - | - |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
NYMX Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | ||||
| 3 y | 3 years | $171 M | $16 M | ||
| 5 y | 5 years | $327 M | $16 M | ||
| alltime | all time | $327 M | $12 M |
Nymox Pharmaceutical Enterprise Value History
| Date | Value |
|---|---|
| 2022 | $27.73 M(-75.0%) |
| 2021 | $110.77 M(-41.7%) |
| 2020 | $190.16 M(+25.4%) |
| 2019 | $151.59 M(+97.4%) |
| 2018 | $76.78 M(-58.5%) |
| 2017 | $185.20 M(+42.4%) |
| 2016 | $130.05 M(-8.1%) |
| 2015 | $141.44 M(+879.8%) |
| 2014 | $14.44 M(-93.1%) |
| 2013 | $210.16 M(-8.3%) |
| 2012 | $229.28 M(-13.6%) |
| 2011 | $265.29 M(+22.7%) |
| 2010 | $216.15 M(+52.2%) |
| Date | Value |
|---|---|
| 2009 | $141.99 M(+38.8%) |
| 2008 | $102.33 M(-39.4%) |
| 2007 | $168.90 M(+74.9%) |
| 2006 | $96.60 M(+71.0%) |
| 2005 | $56.48 M(-21.3%) |
| 2004 | $71.74 M(-12.9%) |
| 2003 | $82.37 M(+3.9%) |
| 2002 | $79.31 M(-8.7%) |
| 2001 | $86.87 M(+112.6%) |
| 2000 | $40.85 M(-25.6%) |
| 1999 | $54.91 M(-44.1%) |
| 1998 | $98.14 M(-20.9%) |
| 1997 | $124.07 M |
FAQ
- What is the all time high enterprise value for Nymox Pharmaceutical?
What is the all time high enterprise value for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high enterprise value is $327.13 M